ANCOVA with treatment group and center as qualitative factors and baseline value as covariate | Applicable for analyses at visits 5 and 7 for both treatment comparisons Tr14 injection solution against the comparators dexamethasone and placebo, respectively |
• Change from baseline in abduction-rotation pain VAS for active external rotation | |
• Changes from baseline in ROM for abduction rotation as goniometry in degrees (active external, active internal, passive external, passive internal rotation) | |
• Changes from baseline in ROM for hand-back range and hand-neck range as distance measurement in cm | |
• Changes in DASH | |
Repeated measurements ANCOVA with treatment group, center, visit and treatment-by-visit interaction as qualitative factors and baseline value as covariate | Visits 5 and 7 included in analysis; both treatment comparisons Tr14 injection solution against the comparators dexamethasone and placebo, respectively: |
• Change from baseline in abduction-rotation pain VAS for active external rotation | |
Logistic regression model with treatment group, center and baseline value (positive/negative) as qualitative factors | Applicable for analyses at visits 5 and 7 for both treatment comparisons Tr14 injection solution against the comparators dexamethasone and placebo, respectively: |
• Jobe | |
• Painful arc | |
Cochran-Mantel-Haenszel (CMH) test for ordered categorical responses stratified by center | Applicable for analyses at visits 5 and 7 for both treatment comparisons Tr14 injection solution against the comparators dexamethasone and placebo, respectively: |
• Patient’s global assessment | |
• Investigator’s global assessment |